63.95 USD
↗ 2.84 (4.65%)AT CLOSE (11:59 AM EDT)
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSANASDAQ • USD
64.00
↗ 0.05 (0.08%)
POST MARKET (AS OF 07:19 PM EDT)
Post Market
AS OF 07:19 PM EDT
64.00
↗ 0.05 (0.08%)
Market: CLOSED
Shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) are trading at $63.94. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 17, 2026.
Open?$60.09
High?$64.63
Low?$60.07
Prev. Close?$61.11
Volume?712.5K
Avg. Volume?868.2K
VWAP?$63.59
Rel. Volume?0.82x
Bid / Ask
Bid?$51.83 × 100
Ask?$76.95 × 100
Spread?$25.12
Midpoint?$64.39
Valuation & Ratios
Market Cap?4.7B
Shares Out?46.3M
Float?38.9M
Float %?84.2%
P/E Ratio?64.36
P/B Ratio?7.76
EPS?$0.95
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
LONDON, W1J 7NJ
Phone: (781) 431-9100
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?87
Short Sent.?36
Piotroski F-Score?5/9Mixed
Altman Z-Score?14.02Safe
Confidence?61%Moderate
Short InterestHigh
Short % of Float?10.68%High
Short Interest?4.2M
Days to Cover?2.9
Free Float38.9M
Avg Daily Volume1.4M
Settlement Date2026-06-30
Financial Health
Current Ratio?3.79Strong
Quick Ratio?3.33Strong
Cash Ratio?1.21Strong
Debt/Equity?0.12Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?64.4PRICEY▾
Peers100
S&P8
P/B?7.76FAIR▾
Peers100
S&P24
P/S?6.24FAIR▾
Peers100
S&P20
P/FCF?28.6FAIR▾
Peers100
S&P32
EV/EBITDA?48.3HIGH▾
Peers100
S&P3
EV/Sales?6.08HIGH▾
Peers100
S&P27
Returns & Efficiency
ROE?12.1%STRONG▾
Peers50
S&P43
ROA?8.9%STRONG▾
Peers50
S&P70
Cash Flow & Enterprise
FCF?$164.2M
Enterprise Value?$4.6B
Fundamentals ratios updated end of day